FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Changes in lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and paraoxonase-1 activities in patients with colorectal cancer

Authorized Users Only
2019
Authors
Mihajlović, Marija
Gojković, Tamara
Vladimirov, Sandra
Miljković, Milica
Stefanović, Aleksandra
Vekić, Jelena
Zeljković, Dejan
Trifunović, Bratislav
Kotur-Stevuljević, Jelena
Spasojević-Kalimanovska, Vesna
Zeljković, Aleksandra
Article (Published version)
Metadata
Show full item record
Abstract
Background: Previous studies revealed decreased level of high-density lipoprotein cholesterol (HDL-C) as important factor for development of colorectal cancer (CRC). Quantity and structure of HDL particles depend on activities of lipid transfer proteins lecithin:cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP), but this topic is largely unexplored in CRC. The main objective of this study was to investigate activities of LCAT and CETP in patients with CRC. Additionally, we analyzed activity of paraoxonase-1 (PON-1), as a main carrier of HDL-antioxidant function. Materials and methods: Ninety-nine CRC patients and 101 healthy individuals were included. LCAT and CETP activities were assessed by measuring rates of formation and transfer of cholesteryl esters. PON-1 paraoxonase and arylesterase activities were measured. Results: Lower levels of HDL-C (p lt .001) were observed in cohort of patients, alongside with decreased LCAT (p lt .050) and increased C...ETP activity (p lt .050). Both PON-1 activities were diminished in CRC (p lt .050 and p lt .001 respectively). Univariate logistic regression singled out HDL-C level (OR = 0.218, p lt .001), CETP activity (OR = 1.010, p lt .01) and mass (OR = 0.994, p lt .001) as possible markers of elevated CRC risk. CETP mass maintained its predictive significance when adjusted for traditional risk factors and level of oxidative stress (OR = 0.993, p lt .001; OR = 0.982, p lt .050, respectively). Conclusion: Our results demonstrated increased CETP and decreased LCAT and PON-1 activities in CRC patients. In preliminary analysis CETP mass was identified as potential significant predictor of CRC development, suggesting that alterations in HDL-C levels, alongside with changes in HDL structure might have a role in carcinogenesis.

Keywords:
Lecithin:cholesterol acyltransferase / Cholesteryl ester transfer protein / Paraoxonase-1 / Prooxidant/antioxidant balance / Colorectal cancer
Source:
Clinical Biochemistry, 2019, 63, 32-38
Publisher:
  • Pergamon-Elsevier Science Ltd, Oxford
Funding / projects:
  • Interactive role of dyslipidemia, oxidative stress and inflammation in atherosclerosis and other diseases: genetic and biochemical markers (RS-175035)

DOI: 10.1016/j.clinbiochem.2018.11.010

ISSN: 0009-9120

PubMed: 30500525

WoS: 000454247400005

Scopus: 2-s2.0-85057453833
[ Google Scholar ]
19
10
URI
https://farfar.pharmacy.bg.ac.rs/handle/123456789/3334
Collections
  • Radovi istraživača / Researchers’ publications
Institution/Community
Pharmacy
TY  - JOUR
AU  - Mihajlović, Marija
AU  - Gojković, Tamara
AU  - Vladimirov, Sandra
AU  - Miljković, Milica
AU  - Stefanović, Aleksandra
AU  - Vekić, Jelena
AU  - Zeljković, Dejan
AU  - Trifunović, Bratislav
AU  - Kotur-Stevuljević, Jelena
AU  - Spasojević-Kalimanovska, Vesna
AU  - Zeljković, Aleksandra
PY  - 2019
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3334
AB  - Background: Previous studies revealed decreased level of high-density lipoprotein cholesterol (HDL-C) as important factor for development of colorectal cancer (CRC). Quantity and structure of HDL particles depend on activities of lipid transfer proteins lecithin:cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP), but this topic is largely unexplored in CRC. The main objective of this study was to investigate activities of LCAT and CETP in patients with CRC. Additionally, we analyzed activity of paraoxonase-1 (PON-1), as a main carrier of HDL-antioxidant function. Materials and methods: Ninety-nine CRC patients and 101 healthy individuals were included. LCAT and CETP activities were assessed by measuring rates of formation and transfer of cholesteryl esters. PON-1 paraoxonase and arylesterase activities were measured. Results: Lower levels of HDL-C (p  lt  .001) were observed in cohort of patients, alongside with decreased LCAT (p  lt  .050) and increased CETP activity (p  lt  .050). Both PON-1 activities were diminished in CRC (p  lt  .050 and p  lt  .001 respectively). Univariate logistic regression singled out HDL-C level (OR = 0.218, p  lt  .001), CETP activity (OR = 1.010, p  lt  .01) and mass (OR = 0.994, p  lt  .001) as possible markers of elevated CRC risk. CETP mass maintained its predictive significance when adjusted for traditional risk factors and level of oxidative stress (OR = 0.993, p  lt  .001; OR = 0.982, p  lt  .050, respectively). Conclusion: Our results demonstrated increased CETP and decreased LCAT and PON-1 activities in CRC patients. In preliminary analysis CETP mass was identified as potential significant predictor of CRC development, suggesting that alterations in HDL-C levels, alongside with changes in HDL structure might have a role in carcinogenesis.
PB  - Pergamon-Elsevier Science Ltd, Oxford
T2  - Clinical Biochemistry
T1  - Changes in lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and paraoxonase-1 activities in patients with colorectal cancer
VL  - 63
SP  - 32
EP  - 38
DO  - 10.1016/j.clinbiochem.2018.11.010
ER  - 
@article{
author = "Mihajlović, Marija and Gojković, Tamara and Vladimirov, Sandra and Miljković, Milica and Stefanović, Aleksandra and Vekić, Jelena and Zeljković, Dejan and Trifunović, Bratislav and Kotur-Stevuljević, Jelena and Spasojević-Kalimanovska, Vesna and Zeljković, Aleksandra",
year = "2019",
abstract = "Background: Previous studies revealed decreased level of high-density lipoprotein cholesterol (HDL-C) as important factor for development of colorectal cancer (CRC). Quantity and structure of HDL particles depend on activities of lipid transfer proteins lecithin:cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP), but this topic is largely unexplored in CRC. The main objective of this study was to investigate activities of LCAT and CETP in patients with CRC. Additionally, we analyzed activity of paraoxonase-1 (PON-1), as a main carrier of HDL-antioxidant function. Materials and methods: Ninety-nine CRC patients and 101 healthy individuals were included. LCAT and CETP activities were assessed by measuring rates of formation and transfer of cholesteryl esters. PON-1 paraoxonase and arylesterase activities were measured. Results: Lower levels of HDL-C (p  lt  .001) were observed in cohort of patients, alongside with decreased LCAT (p  lt  .050) and increased CETP activity (p  lt  .050). Both PON-1 activities were diminished in CRC (p  lt  .050 and p  lt  .001 respectively). Univariate logistic regression singled out HDL-C level (OR = 0.218, p  lt  .001), CETP activity (OR = 1.010, p  lt  .01) and mass (OR = 0.994, p  lt  .001) as possible markers of elevated CRC risk. CETP mass maintained its predictive significance when adjusted for traditional risk factors and level of oxidative stress (OR = 0.993, p  lt  .001; OR = 0.982, p  lt  .050, respectively). Conclusion: Our results demonstrated increased CETP and decreased LCAT and PON-1 activities in CRC patients. In preliminary analysis CETP mass was identified as potential significant predictor of CRC development, suggesting that alterations in HDL-C levels, alongside with changes in HDL structure might have a role in carcinogenesis.",
publisher = "Pergamon-Elsevier Science Ltd, Oxford",
journal = "Clinical Biochemistry",
title = "Changes in lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and paraoxonase-1 activities in patients with colorectal cancer",
volume = "63",
pages = "32-38",
doi = "10.1016/j.clinbiochem.2018.11.010"
}
Mihajlović, M., Gojković, T., Vladimirov, S., Miljković, M., Stefanović, A., Vekić, J., Zeljković, D., Trifunović, B., Kotur-Stevuljević, J., Spasojević-Kalimanovska, V.,& Zeljković, A.. (2019). Changes in lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and paraoxonase-1 activities in patients with colorectal cancer. in Clinical Biochemistry
Pergamon-Elsevier Science Ltd, Oxford., 63, 32-38.
https://doi.org/10.1016/j.clinbiochem.2018.11.010
Mihajlović M, Gojković T, Vladimirov S, Miljković M, Stefanović A, Vekić J, Zeljković D, Trifunović B, Kotur-Stevuljević J, Spasojević-Kalimanovska V, Zeljković A. Changes in lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and paraoxonase-1 activities in patients with colorectal cancer. in Clinical Biochemistry. 2019;63:32-38.
doi:10.1016/j.clinbiochem.2018.11.010 .
Mihajlović, Marija, Gojković, Tamara, Vladimirov, Sandra, Miljković, Milica, Stefanović, Aleksandra, Vekić, Jelena, Zeljković, Dejan, Trifunović, Bratislav, Kotur-Stevuljević, Jelena, Spasojević-Kalimanovska, Vesna, Zeljković, Aleksandra, "Changes in lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and paraoxonase-1 activities in patients with colorectal cancer" in Clinical Biochemistry, 63 (2019):32-38,
https://doi.org/10.1016/j.clinbiochem.2018.11.010 . .

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB